Nu-Med Plus (NUMD) Total Current Liabilities (2011 - 2025)
Nu-Med Plus recorded quarterly Total Current Liabilities of $279189.0 in Q4 2025, up 5.87% quarter-over-quarter from $263708.0 in Q3 2025, and up 24.38% year-over-year from $224469.0 in Q4 2024.
Nu-Med Plus' Total Current Liabilities history runs 15 years deep, the most recent figure standing at $279189.0 for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 24.38% year-over-year to $279189.0; the TTM figure through Dec 2025 stood at $279189.0 (up 24.38% YoY), while the FY2025 annual figure was $279189.0, up 24.38% from the prior year.
- Total Current Liabilities came in at $279189.0 for Q4 2025 at Nu-Med Plus, up from $263708.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $279189.0 in Q4 2025 to a low of $84674.0 in Q1 2021.
- A 5-year average of $188808.2 and a median of $187249.0 in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities slumped 79.57% in 2021 and surged 181.47% in 2022, its largest moves.
- Nu-Med Plus' Total Current Liabilities stood at $154521.0 in 2021, then dropped by 7.73% to $142570.0 in 2022, then advanced by 12.37% to $160207.0 in 2023, then soared by 40.11% to $224469.0 in 2024, then increased by 24.38% to $279189.0 in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $279189.0, $263708.0, and $254857.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Nu-Med Plus | - | - | - | 279,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 279,189.00 |
| Sep 30, 2025 | 263,708.00 |
| Jun 30, 2025 | 254,857.00 |
| Mar 31, 2025 | 240,202.00 |
| Dec 31, 2024 | 224,469.00 |
| Sep 30, 2024 | 211,382.00 |
| Jun 30, 2024 | 196,905.00 |
| Mar 31, 2024 | 177,593.00 |
| Dec 31, 2023 | 160,207.00 |
| Sep 30, 2023 | 145,703.00 |
| Jun 30, 2023 | 152,096.00 |
| Mar 31, 2023 | 150,298.00 |
| Dec 31, 2022 | 142,570.00 |
| Sep 30, 2022 | 273,299.00 |
| Jun 30, 2022 | 255,521.00 |
| Mar 31, 2022 | 196,937.00 |
| Dec 31, 2021 | 154,521.00 |
| Sep 30, 2021 | 121,253.00 |
| Jun 30, 2021 | 90,781.00 |
| Mar 31, 2021 | 84,674.00 |
| Dec 31, 2020 | 80,048.00 |
| Sep 30, 2020 | 418,502.00 |
| Jun 30, 2020 | 431,267.00 |
| Mar 31, 2020 | 414,546.00 |
| Dec 31, 2019 | 416,211.00 |
| Sep 30, 2019 | 387,079.00 |
| Jun 30, 2019 | 360,039.00 |
| Mar 31, 2019 | 379,169.00 |
| Dec 31, 2018 | 374,489.00 |
| Sep 30, 2018 | 353,987.00 |
| Jun 30, 2018 | 355,256.00 |
| Mar 31, 2018 | 337,556.00 |
| Dec 31, 2017 | 327,910.00 |
| Sep 30, 2017 | 401,875.00 |
| Jun 30, 2017 | 399,763.00 |
| Mar 31, 2017 | 386,398.00 |
| Dec 31, 2016 | 4.47 Mn |
| Sep 30, 2016 | 389,490.00 |
| Jun 30, 2016 | 367,463.00 |
| Mar 31, 2016 | 380,965.00 |
| Dec 31, 2015 | 15.30 Mn |
| Sep 30, 2015 | 278,726.00 |
| Jun 30, 2015 | 275,749.00 |
| Mar 31, 2015 | 276,580.00 |
| Dec 31, 2014 | 266,828.00 |
| Sep 30, 2014 | 266,828.00 |
| Jun 30, 2014 | 259,102.00 |
| Mar 31, 2014 | 257,458.00 |
| Dec 31, 2013 | 220,362.00 |
| Sep 30, 2013 | 212,326.00 |
| Jun 30, 2013 | 234,692.00 |
| Mar 31, 2013 | 198,888.00 |
| Dec 31, 2012 | 156,487.00 |
| Dec 31, 2011 | 1,700.00 |